Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s (FDA’s) recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).


AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced detailed preliminary clinical trial results for the world’s first drug-coated scoring balloon catheter.

Clear Image Devices LLC (CiD) announced the release of its step platform to be used for standing patient ultrasound venous insufficiency studies. The Ultrasound Exam Steps enable sonographers to place the patient in the optimal position for safe, easy capture of the highest quality venous images of the upper and lower leg.

To help reduce the burden of cardiovascular disease, the nation's leading killer, New York-Presbyterian Hospital and Weill Cornell Medical College have created the Dalio Institute of Cardiovascular Imaging. Raymond T. Dalio, a life trustee of New York-Presbyterian Hospital, has made a gift of $20 million through his Dalio Foundation in support of the institute.

The Eurozone economic slowdown has made it difficult for hospitals, particularly in Southern Europe, to procure new imaging modalities. With streamlined budgets and escalating number of medical procedures, the need to spend less on technologies while gaining the maximum benefit from them has sustained demand for high-quality refurbished imaging equipment.



The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries.


InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) trial demonstrating that the MGuard outperformed bare metal and drug-eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients.

Subscribe Now